Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per specialist: Ulrike Lorch, MD FRCA FFPM
Woman and Man Max 99 years
Ulrike Lorch, MD FRCA FFPM
Update Il y a 4 ans
Open Label Pharmacokinetic Study of OZ439 and Piperaquine on Administration of OZ439+TPGS Granules for Oral Suspension Alone or With Either Piperaquine Phosphate Tablets or Granules for Oral Solution in Healthy Volunteers
A healthy volunteer study to characterise the exposure of the two study medications, following administration of OZ439 + TPGS granules with piperaquine phosphate granules (intended for chi...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Ulrike Lorch, MD FRCA FFPM
Update Il y a 4 ans
Food and Insulin Effect on QT/QTC Interval of ECG
Moxifloxacin is routinely used as a probe to confirm assay sensitivity in thorough electrocardiogram (ECG) studies. It has been shown that a meal shortens the QT interval, which may affect...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Ulrike Lorch, MD FRCA FFPM
Update Il y a 4 ans
Effect of Glucose on QTc Interval in Type 1 Diabetes
High blood glucose levels (hyperglycaemia) and Moxifloxacin (a commonly used antibiotic) have both been shown independently to affect heart activity in healthy volunteers as recorded by EC...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Ulrike Lorch, MD FRCA FFPM
Update Il y a 4 ans
Healthy Volunteer Study of the Pharmacokinetics of Oral Piperaquine With OZ439 + TPGS Formulation in the Fasted State
Piperaquine tablets (coated) + OZ439 granules + TPGS granules will be co-administered in Phase IIb (adults). However, safety and PK data (for OZ439 plus piperaquine) were obtained using pi...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Ulrike Lorch, MD FRCA FFPM
Update Il y a 4 ans
Phase I Study of the Safety, Tolerability, PK & PD of Lomitapide in Japanese and Caucasian Subjects With Elevated LDL-C
This is a randomized, double-blind, placebo-controlled, single ascending dose (SAD) and multiple ascending dose (MAD) study of orally administered lomitapide in healthy male Japanese and C...
Country
None
organs
None
Specialty
None
Closed trial
More information